SEI Investments’s iRadimed IRMD Stock Holding History

SEI Investments’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.56M	Sell	47,686 -26,618	-36%	-$2.42M	﹤0.01%	1551
2026 Q1	$7.15M	Buy	74,304 +10,908	+17%	+$1.09M	0.01%	1313
2025 Q4	$6.17M	Buy	63,396 +39,368	+164%	+$3.38M	0.01%	1290
2025 Q3	$1.71M	Buy	24,028 +1,556	+7%	+$104K	﹤0.01%	1766
2025 Q2	$1.35M	Buy	22,472 +4,848	+28%	+$266K	﹤0.01%	1803
2025 Q1	$924K	Buy	17,624 +4,874	+38%	+$274K	﹤0.01%	1935
2024 Q4	$703K	Buy	12,750 +686	+6%	+$36.1K	﹤0.01%	2072
2024 Q3	$606K	Buy	12,064 +1,617	+15%	+$74.6K	﹤0.01%	2116
2024 Q2	$459K	Buy	10,447 +3,896	+59%	+$166K	﹤0.01%	2193
2024 Q1	$288K	Buy	6,551 +2,307	+54%	+$102K	﹤0.01%	2319
2023 Q4	$201K	Buy	+4,244	New	+$178K	﹤0.01%	2435
2023 Q3	–	Sell	-4,244	Closed	-$203K	–	2652
2023 Q2	$203K	Buy	+4,244	New	+$191K	﹤0.01%	2476

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments's IRMD Position: Q2 2026 in Review

SEI Investments reduced its iRadimed (IRMD) stake by 36% in Q2 2026, selling an estimated $2.42M and leaving 47,686 shares worth $4.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

SEI Investments first reported a position in IRMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.15M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

SEI Investments held 47,686 shares of iRadimed worth $4.56M as of Q2 2026.
SEI Investments sold 26,618 iRadimed shares in Q2 2026, an estimated $2.42M.
iRadimed made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1551 holding.
SEI Investments first reported a position in iRadimed in Q2 2023 and has held it in 12 quarters since.
SEI Investments's iRadimed position peaked at $7.15M in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.